NCT00917254View on ClinicalTrials.gov

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Venous Thromboembolism
Interventions
DRUG

YM150

oral

DRUG

Placebo

oral

DRUG

Enoxaparin

injection

Trial Locations (13)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyusyu

Tōhoku

Changhua

Chiayi City

Kaohsiung City

Taichung

Bangkok

Chiang Mai

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00917254 - Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery | Biotech Hunter | Biotech Hunter